Your browser doesn't support javascript.
loading
Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004-2015.
Jiang, Miao; Near, Aimee M; Desta, Barnabas; Wang, Xia; Hammond, Edward R.
Affiliation
  • Jiang M; BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.
  • Near AM; Real-World Evidence, IQVIA, Durham, North Carolina, USA.
  • Desta B; BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA Barnabas.Desta@astrazeneca.com.
  • Wang X; BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.
  • Hammond ER; BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.
Lupus Sci Med ; 8(1)2021 09.
Article in En | MEDLINE | ID: mdl-34521733

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cost of Illness / Lupus Erythematosus, Systemic Type of study: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Humans Country/Region as subject: America do norte Language: En Journal: Lupus Sci Med Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cost of Illness / Lupus Erythematosus, Systemic Type of study: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Humans Country/Region as subject: America do norte Language: En Journal: Lupus Sci Med Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom